Policy Archives - MPR


National Guideline Clearinghouse Offline Due to Funding Cuts

“We believe it is important for providers to have access to evidence-based guidelines when they need them, which is why health insurance providers were an early supporter and sponsor of this project,” Cathryn Donaldson, Director of Communications & Public Affairs for AHIP, said in a statement.

FDA Outlines Plan for Increasing Nonprescription Drug Availability


The draft guidance, Innovative Approaches for Nonprescription Drug Products, applies to drugs under the New Drug Application (NDA) process and “is intended to extend that NDA pathway to include therapeutic indications that have not, historically, been available for use without a prescription,” said Gottlieb in a press statement.